Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Santiage versus Dysport for correction of glabellar lines
IRCT20150101020514N30Phase 3Completed
- Sponsor
- Nano Daru
- Start
- Aug 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of botulinum toxin type A in glabellar furrowing (2 arms), sponsored by Nano Daru. Primary endpoint: Percentage of subjects with improvement in glabellar lines at maximum frown. Started Aug 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on IRCT20150101020514N30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150101020514N30.